Cart
sales@molnova.com
ADP - Ribosylation Factor 6, ARF6 (2 - 13)
CAS No. ———
ADP - Ribosylation Factor 6, ARF6 (2 - 13)( ——— )
Catalog No. M41944 CAS No. ———
ADP - Ribosylation Factor 6, ARF6 (2 - 13)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameADP - Ribosylation Factor 6, ARF6 (2 - 13)
-
NoteResearch use only, not for human use.
-
Brief DescriptionADP - Ribosylation Factor 6, ARF6 (2 - 13)
-
DescriptionADP - Ribosylation Factor 6, ARF6 (2 - 13)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight1319.58
-
Molecular FormulaC60H102N16O17
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
inS3-54-A26
inS3-54-A26, a novel inhibitor of the DNA-binding domain (DBD) of STAT3, suppresses tumor growth, metastasis and STAT3 target gene expression in vivo.
-
H3B-120
H3B-120 is a highly selective, competitive, and allosteric carbamoyl phosphate synthetase 1 (CPS1) inhibitor (IC50: 1.5 μM; Ki: 1.4 μM) with anti-cancer activity.
-
SR8278
SR8278 is an REV-ERBα antagonist(EC50 = 0.47 μM) blocking activation of the receptor by the synthetic agonist GSK 4112.
